• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.79% Nasdaq Up0.53%

    NanoViricides, Inc. (NNVC)

    -NYSE MKT
    1.75 Up 0.02(1.16%) Jul 1, 4:03PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    NanoViricides, Inc.
    135 Wood Street
    Suite 205
    West Haven, CT 06516
    United States - Map
    Phone: 203-937-6137
    Website: http://www.nanoviricides.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:6

    Business Summary 

    NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could enable a functional cure for HIV/AIDS. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; Nanoviricide anti-viral eye drops against external eye viral infections; DengueCide, a treatment against Dengue viruses; RabiCide, an anti-rabies nanoviricide; and Nanoviricide for the treatment of various strains of Ebola and Marburg filoviruses. The company has licenses to develop drugs for the treatment of human viral diseases, such as H5N1 (avian flu), human influenza, human immunodeficiency virus (HIV/AIDS), hepatitis B virus, hepatitis C virus, herpes simplex virus, and rabies; and dengue viruses, Japanese encephalitis virus, West Nile virus, viruses causing viral conjunctivitis and ocular herpes, and Ebola/Marburg viruses, as well as viral diseases of the eye comprising epidemic kerato-conjunctivitis and herpes keratitis. NanoViricides, Inc. was founded in 2005 and is based in West Haven, Connecticut.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on NanoViricides, Inc.

    Corporate Governance 
    NanoViricides, Inc.’s ISS Governance QuickScore as of Jun 1, 2015 is 6. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 6; Compensation: 4.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Dr. Anil R. Diwan Ph.D., 56
    Chairman, Pres and Sec.
    275.00K0.00
    Dr. Eugene Seymour M.D., MPH, 75
    Chief Exec. Officer and Director
    275.00K0.00
    Ms. Meeta R. Vyas SB, MBA, 56
    Chief Financial Officer
    108.00K0.00
    Dr. Randall W. Barton Ph.D., 68
    Chief Scientific Officer and Chief Regulatory Officer
    N/AN/A
    Dr. Jayant Tatake Ph.D.,
    VP of R&D
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders